5-MAPB: Difference between revisions

Line 7:

| ''[[ 5-MAPB/Summary|Summary sheet: 5-MAPB]]''

|}

'''5-(2-methylaminopropyl)benzofuran''' (abbreviated '''5-MAPB''') is a synthetic [[Psychoactive class::entactogen]] of the substituted [[chemical class::benzofuran]] class of chemicals, which are known to produce ~~physical and cognitive~~[[euphoria]], [[stimulant|~~stimulation~~]] and mildly [[hallucinogen]]ic effects. These include such [[MDA]]-inspired substances as [[5-APB]], [[6-APB]] and [[5-EAPB]], among others. 5-MAPB is the N-methylated form of [[5-APB]], analogously to how [[MDMA]] is the N-methylated form of [[MDA]].

'''5-(2-methylaminopropyl)benzofuran''' (abbreviated '''5-MAPB''') is a synthetic [[Psychoactive class::entactogen]] of the substituted [[chemical class::benzofuran]] class of chemicals, which are known to produce [[euphoria|euphoric]], [[entactogen]]ic, [[stimulant|stimulating]] and mildly [[hallucinogen]]ic effects. These include such [[MDA]]-inspired substances as [[5-APB]], [[6-APB]] and [[5-EAPB]], among others. 5-MAPB is the N-methylated form of [[5-APB]], analogously to how [[MDMA]] is the N-methylated form of [[MDA]].

This compound is known for its [[stimulating]], [[euphoria|euphoric]] and [[entactogen]]ic effects that is capable of acting a quasi-substitute for [[MDMA]] proper, which has resulted in its rise in popularity as a [[research chemical]] that is easily accessible through the use of online vendors. It has been sold as a [[designer drug]] since 2010.<ref>EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA | http://www.emcdda.europa.eu/publications/implementation-reports/2010</ref>

@@ Line 7: / Line 7: @@
 | ''[[ 5-MAPB/Summary|Summary sheet:  5-MAPB]]''
 |}
-'''5-(2-methylaminopropyl)benzofuran''' (abbreviated '''5-MAPB''') is a synthetic [[Psychoactive class::entactogen]] of the substituted [[chemical class::benzofuran]] class of chemicals, which are known to produce physical and cognitive[[euphoria]], [[stimulant|stimulation]] and mildly [[hallucinogen]]ic effects. These include such [[MDA]]-inspired substances as [[5-APB]], [[6-APB]] and [[5-EAPB]], among others. 5-MAPB is the N-methylated form of [[5-APB]], analogously to how [[MDMA]] is the N-methylated form of [[MDA]].
+'''5-(2-methylaminopropyl)benzofuran''' (abbreviated '''5-MAPB''') is a synthetic [[Psychoactive class::entactogen]] of the substituted [[chemical class::benzofuran]] class of chemicals, which are known to produce [[euphoria|euphoric]], [[entactogen]]ic, [[stimulant|stimulating]] and mildly [[hallucinogen]]ic effects. These include such [[MDA]]-inspired substances as [[5-APB]], [[6-APB]] and [[5-EAPB]], among others. 5-MAPB is the N-methylated form of [[5-APB]], analogously to how [[MDMA]] is the N-methylated form of [[MDA]].
 This compound is known for its [[stimulating]], [[euphoria|euphoric]] and [[entactogen]]ic effects that is capable of acting a quasi-substitute for [[MDMA]] proper, which has resulted in its rise in popularity as a [[research chemical]] that is easily accessible through the use of online vendors. It has been sold as a [[designer drug]] since 2010.<ref>EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA | http://www.emcdda.europa.eu/publications/implementation-reports/2010</ref>